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Osteoarthritis (OA)
0.

Signs & Symptoms

• Pain: Affecting joints and acute pain during or after joint
movements.
• Stiffness: Joint and muscle stiffness after periods of inactivity
or upon awakening
• Swelling: Soft tissue inflammation around joints.
• Synovitis: in advanced stages
• Loss of Flexibility or Motion: Unable to move joints through
full range of motion
• Tenderness: Light pressure or tenderness near the inflamed
joint
• Bone Spurs: Hard lumps can form around the joint and cause
severe pain
• Grating Sensation: During joint movements may experience
a popping or crackling sensation

Underlying Pathophysiology

(Primary-idiopathic vs. Secondary-trauma or mechanical
misalignment)
• Multifactoral, not just a degenerative disease of cartilage
• Involves: trauma, mechanical forces, inflammation,
biochemical reactions, metabolic derangements
• Cartilage is not vascular or innervated, alone will not cause
pain
• Pain from the joint capsule, synovium, subchondral bone,
ligaments, periarticular muscles
• As disease progresses the non-cartilaginous components
are affected:
• bone remodeling
• osteophyte formation
• weakening of periarticular muscles
• laxity of ligaments
• synovial effusion
• Chronic, low-grade inflammation, innate immune
mechanisms
• Synovial fluid contains inflammatory mediators including:
• Plasma proteins (c-reactive protein)
• Prostaglandins (PGE2)
• Leukotrenes (LKB4)
• Cytokines (TNF, IL1-beta, IL6, IL15, IL17, IL18, IL21)
• Growth factors (TGF-beta, FGFs, VEGF, NGF)
• Nitric oxide
• Complement components
• These mediators induce matrix metalloproteinases and
hydrolytic enzymes that breakdown cartilage d/t proteoglycan
and collagen destruction. WBC molecules are released from
the breakdown of extracellular matrix recognized by the innate
immune cells (macrophages and mast cells). Overtime, tissue
destruction occurs
• Animal studies suggest macrophages play a role in
development of osteophytes (Mora, Przkora, & Cruz-Almeida,
2018)
• Protective growth factor mechanisms lacking with OA:
• Insulin-like
• Platelet-derived
• Fibroblast 18
• TGF-beta

Significance of Pathophysiology

Understanding the underlying cause is key for preventing,
slowing the progression of and developing the best treatment
plan. Exercise has been proven to decrease pain and morbidity in
OA patients. “Muscle around the affected joints become stronger,
bone loss and joint swelling decrease, and stiffness and pain
improve
thanks
to
a
better
lubrication
of
the
cartilage”(Castrogiovanni, etal, 2019, P. 2)
OA Prevention-physical activity
(Rat studies suggest moderate physical activity is the key)
• Synovium has multiple functions:
• Lubrication
• Phagocytosis
• Immune function
• Articular cartilage is avascular
• Diffusion through synovial fluid to chondrocytes provide
cartilage nourishment
• Superficial cellular lining of synovium is composed of two
synoviocytes:
• Type A- vacuoles related to macrophages (phagocytic
function)
• Type B- secretory fibroblast, producing hyaluronan
• Together, Type A and Type B diminish joint friction
• Extracellular matrix contains lubricating molecules:
• Collagen
• Prosteoglycans
• These are the semi-permeable membrane of synovial
solute
• Rat study examined the impact moderate physical activity had
on synovium:
• Pro-inflammatory molecules (IL-14, IL-10, TNF-alpha)
• OA related enzymes (MMP-13)
• Anti-inflammatory cytokines (IL-4, IL-10)
• Chondroprotective markers (lubricin)
“Exercise therapy may decrease cytokines and related genes
expression and inhibit inflammatory factors-mediated cartilage
degradation, through the synthesis of IL-10 by synoviocytes type
A, thus, effectively blocking cartilage damage” (Castrogiovanni,
etal, 2019, p.9)
Importance of Vitamin D
(One randomized controlled pilot trial suggested Vitamin
D decreased pain in patients with low levels)
• Vitamin D impact on prevention and treatment:
• Increases bone mass
• Prevents bone loss
• Obtained from
• Diet (fish, mushrooms, eggs, liver)
• Ultraviolet light
• Supplement 1000 International Units (IU)/d over
60 years age
• Increases calcium absorption through the endocrine
pathway
• Metabolized in the liver
• Vitamin D-cellular level:
• TGF-beta binds to its receptor and phosphorylates
SMAD3 and suppresses MMP13 expression
• Vitamin D may be involved with TGF-beta/SMAD
pathways
• Cartilage damage and early osteophyte development
are associated with lack of TGF-beta in mice who
develop OA
In vitro studies suggest vitamin D may inhibit the progression of
OA in humans by interacting with TGF-beta, however more
studies are indicated (Parks, 2019)

Introduction

Osteoarthritis (OA) is the primary cause of chronic pain, affecting approximately Twenty-seven million people
in the United States. OA is a disease of the synovial joint, mostly causing pain in hips, knees, hands and facet
joints of the spine (Miller, R., Tran, P., Obeidat, A., Raghu, P., Ishihara, S., Miller, R. & Malfait, A., 2015). In humans,
knees are the largest synovial joint. In early stages pain is described as “sharp” but chronically progresses into a
“dull/achy” pain debilitated many, once active individuals. Treatment options consist of pharmacological and as
well as surgical interventions. “OA is the principal diagnosis associated with total knee replacement”, (Miller,
2015, p.318).
Human beings are living longer than ever before. This fact broadens the patient population of those affected
by OA. Anybody can be affected from the progressive wear and tear and degeneration of joints over a life-span.
Being older than 65, obese, and of African American descent puts those at greater risk for developing OA (Mora, J.,
Przkora, R. & Cruz-Almeida, Y., 2018).

Presentation of Case

A 62-year-old African American male presents to the office complaining of progressively worse dull-achy
pain in his left knee that is really stiff. He was physically active in his younger years but his exercise has slowly
come to a halt. He has been diagnosed with type two diabetes mellitus and has a BMI of 30. He states that his
knee pain inhibits him from exercise. An x-ray showed visible osteophytes. A joint aspiration and MRI indicate the
presence of OA. After exhausting all traditional treatments, including NSAIDS and intra-articular corticoid
injections, the pain still persists. Patient is instructed to lose some weight through dietary modifications and light
exercise as tolerated. Surgical intervention will be the next treatment option. A primary left total knee
arthroplasty has been scheduled.

(Blas, 2019)

(Cole, 2019)

Implications for Nursing Care

• Risk factors:
• Age
• Prior joint injury
• Obesity
• Genetics
• Males
• African American
• Chief complaint-Pain
• Early onset- “sharp”
• Later stages- chronic- “dull/achy”
• Neuroanatomy of knee joint
• Sensory and sympathetic peripheral nerve fibers
innervate
• Sensory cell bodies located in the dorsal root ganglion L3L5
• Tissue injury/remodeling characteristics, molecules
exiting nociceptors
• Classic molecules- prostaglandins, bradykinins
• Additional molecules-cytokines, chemokines
• Education
• Diet (vitamins, glucosamine sulfate, phytochemicals)
• Pain management
• Weight management
• Psychological (support groups, psychologist, meditation,
holistic medicine)
Phytochemicals from food
(reviewing 5879 articles, Five RCT’s and Four cross-sectional
studies)
• Attributes found to decrease the inflammatory process,
decreasing progression of OA
• Antioxidants
• Vitamin A
• Vitamin C
• Vitamin E
• Phytochemicals
• Fruits
• Vegetables
• Grains
• Beans
• Other plants
• physical activity

Conclusion

(Mora, Przkora, & Cruz-Almeida, 2018)
Abbreviations: OARSI, Osteoarthritis Research Society International; ACR, American
College of Rheumatology; AAOS, American Academy of Orthopedic Surgeons; TENS,
transcutaneous electrical nerve stimulation; NSAIDs, non steroidal antinflammatory drug.

30 million adults in the U.S. are affected by OA. Prevention, delay
of progression and symptom management are multifactorial and
vary slightly amongst each individual. In general, maintaining a
healthy diet, taking vitamins and low-impact regular exercise are
big contributors to slowing the progress, decreasing the risk of OA.
There are many innovative treatment options available to manage
pain to optimize quality of life.

(Mora, Przkora, & Cruz-Almeida, 2018)
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